Quote:
Originally Posted by jeanb
Radiguy,
Good for you for doing research and considering a clinical trial. Fewer than 1% of people with PD participate in clinical trials. (shocking but true!!)
As you can imagine, lack of trial participants adds to the time it takes to get drugs out of research -- through FDA approval -- and ultimately to us.
We need more people like you!!
|
Thankee!
I work at NIH, and a large part of what I do is radio news releases on the importance of clinical research. What kind of hypocrite would I be if I didn't take a shot at something where I might be able to help?
Besides, I'm intrigued by the potential neuroprotective benefits of DBS. I'm only 52. (Yeah, that's right. I said "only.") If I can cut back on the meds and slow down the progression -- to me, it's worth the risks.
Of course, there's a 50 percent chance I get randomized to the control group. It's a flip of the coin.